Refine by
Biomedical Devices Articles & Analysis
53 news found
Exposure typically occurs through inhalation, although occasional outbreaks of cutaneous infection have been traced to contaminated biomedical devices. Various types of aspergillosis include: · Allergic bronchopulmonary aspergillosis (ABPA) · Azole-Resistant Aspergillus fumigatus · Aspergilloma · ...
Exposure typically occurs through inhalation, although occasional outbreaks of cutaneous infection have been traced to contaminated biomedical devices. Various types of aspergillosis include: · Allergic bronchopulmonary aspergillosis (ABPA) · Azole-Resistant Aspergillus fumigatus · Aspergilloma · ...
Lumen Bioscience—a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases—today announced the receipt of a $3.6 million award from the Department of Defense (DoD) for advanced biomedical product development in support of Naval operations. The award from the Medical Technology Consortium (MTEC), a 501(c)(3) biomedical technology consortium ...
The transaction is expected to close in early August 2022. Biorez is a medical device start-up based in New Haven, CT and is focused on advancing the healing of soft tissue using its proprietary BioBrace® Implant technology. ...
That said, with assistance from this initial Phase I SBIR grant and the subsequent Phase II award, our goal is to complete the development of our enhancements to COPA, complete all necessary device, system, and human factors testing, followed by the subsequent submission of our De Novo request for review by the U.S. ...
Their DLP-based bioprinting technology enables high-precision and high-throughput manufacturing of biomedical devices and human tissues for cell culture, drug screening, and regenerative medicine applications. ...
ABK Biomedical, Inc., an innovative, clinical-stage medical device company dedicated to the research, development and commercialization of advanced imageable embolic therapies, announced the first patient treated in ABK’s First-in-Human study with Eye90 microspheres™, a Y90 radioembolization device for the treatment of liver ...
CytoRecovery, Inc., a leader in the marker free enrichment, sorting, and recovery of live cells, presented recent study results at the American Association for Cancer Research (AACR) Annual Meeting 2022 currently being held in New Orleans. The study was completed in collaboration with The Laboratory of Integrative Cancer Immunology, National Cancer Institute (NCI/NIH Bethesda, MD) and Virginia ...
Terray Therapeutics, a biotechnology company propelling drug discovery into the information age, today announced the appointments of Feroze (Fez) Ujjainwalla, PhD, as Head of Business, and Adam D. Hughes, PhD, as Head of Chemistry. They join an expanding lineup of industry veterans including Vanessa Taylor, Terray’s Head of Biology and Preclinical Development, Narbe Mardirossian, ...
Among the best of new innovations in life sciences and biomedicine being unveiled to investors and healthcare leaders at JP Morgan’s BIO Partnering conference this month is KLISBio’s silk-based biomedical technology. Among the company’s developing portfolio of products is SILKBridge®, a first-to-market, silk-based graft for peripheral nerve repair, which is anticipated ...
ByKLISBio
Investors keen to get involved with a company on the forefront of human tissue regeneration will be interested to visit with KLISBio, an international medtech company bringing its silk-based biomedical technology and the first of their products, SILKBridge®, to the Biotech Showcase Jan. 10-19. KLISBio is leading a revolution in restorative surgical procedures using engineered silk ...
ByKLISBio
CAPs produce various reactive oxygen (ROS) and reactive nitrogen species (RNS) (i.e., singlet oxygen (1O2) ozone (O3), super anion (O2-), nitrate oxide (-NO), nitric dioxide (-NO2), and hydroxyl radical (-OH)) which have important biological and biomedical activities. CAPs have been proven to be effective in wound healing, skin diseases, antifungal treatments and have also been ...
FDA-registered life-science and biomedical device company and the Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) announced today that Jerome Canady MD, CEO will be presenting at the Baird Global Healthcare Conference on Tuesday, September 14th from 10:15 to 10:45 AM ET. ...
About US Medical Innovations US Medical Innovations, LLC (USMI) is a private U.S. biomedical device company and wholly owned subsidiary of US Patent Innovations, LLC. USMI’s focus is developing advanced innovative affordable plasma and robotic electrosurgical devices and striving to develop innovative devices in the field ...
Avery Biomedical Devices (Commack, NY), the global leader in high reliability diaphragm pacemakers, announced that its new diaphragm pacemaker transmitter, Spirit, has earned FDA approval and is now being offered to patients using its pacing system. ...
Fourteen year-old Sedarius was recently featured on WSB-TV Atlanta as the first pediatric patient to receive surgery to implant a diaphragm pacemaker in the state of Georgia. Sedarius was diagnosed with CCHS when he was eight years old, and required a tracheotomy and ventilator to breathe while he slept. The Avery Breathing Pacemaker will allow him to breathe without the need for a trach or ...
Medscape Letter Regarding Avery System Avery Biomedical Devices has an outstanding track record spanning over 45 years including an outstanding safety record, long term viability with some patients pacing for more than 35 years, and exceptional patient satisfaction. It is also the only device of its kind with full FDA premarket approval and CE ...
Suono Bio, Inc., the company revolutionizing the treatment of gastrointestinal diseases, today announced it has raised an $8.5 million Series A financing led by Axil Capital and Mizuho Securities Principal Investment, with participation by Taiwania Capital and other investors. Suono Bio will utilize the funds to advance its lead programs in inflammatory bowel disease as well as expansion of its ...
2021 Cohort to Prominently Feature the Industry’s Best and Brightest Startups Working to Transform Patient Care Through Innovation LOS ANGELES — June 15, 2021 — MedTech Innovator, the largest accelerator of medical device companies in the world, today announced the 50 companies selected to participate in the organization’s flagship four-month Showcase ...
About US Medical Innovations US Medical Innovations, LLC (USMI), based in Takoma Park, MD, is a privately held FDA-registered life science and biomedical device company. USMI is dedicated to expanding the boundaries of plasma medicine by pioneering new technologies for the development of state-of-the-art medical devices that advance patient ...